162 results on '"Mourits, Marian J.E."'
Search Results
2. The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
3. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review
4. Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications
5. BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study
6. Increased interferon signalling in vaginal tissue of patients with primary Sjögren’s syndrome
7. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer
8. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers
9. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
10. Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependence
11. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study
12. A Survey of Female Sexual Functioning in the General Dutch Population
13. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
14. Supplementary Methods from Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
15. Data from Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands
16. Supplementary Figure S1 from Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
17. Supplementary Tables 1 through 5 from Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands
18. Data from Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
19. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study
20. Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
21. PMS2-associated Lynch syndrome: Past, present and future
22. Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis
23. Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer:A matched cohort study
24. Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer:course over time and associated factors
25. Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study
26. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis
27. The management of menopausal symptoms in breast cancer survivors: A case-based approach
28. Preoperative physical activity and frailty in older patients undergoing cancer surgery – PREsurgery study
29. Sexual functioning of cervical cancer survivors: A review with a female perspective
30. No (Wo)Man Is an Island—The Influence of Physicians' Personal Predisposition to Labia Minora Appearance on Their Clinical Decision Making: A Cross‐Sectional Survey
31. Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial
32. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis
33. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
34. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers:an international cohort study
35. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants:a Prospective Lynch Syndrome Database report
36. Association of Salpingectomy with Delayed Oophorectomy Versus Salpingo-oophorectomy with Quality of Life in BRCA1/2 Pathogenic Variant Carriers:A Nonrandomized Controlled Trial
37. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
38. Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas
39. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
40. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer
41. The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy
42. Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer
43. Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical Cancer
44. Toward New Strategies to Select Young Endometrial Cancer Patients for Mismatch Repair Gene Mutation Analysis
45. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
46. Gynecologic screening in hereditary nonpolyposis colorectal cancer
47. How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario
48. Tamoxifen treatment and gynecologic side effects: a review
49. Three-group metaphase as a morphologic criterion of progressive cervical intraepithelial neoplasia
50. Discrepancy between Ultrasonography and Hysteroscopy and Histology of Endometrium in Postmenopausal Breast Cancer Patients Using Tamoxifen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.